219 related articles for article (PubMed ID: 11147678)
1. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis.
Nickoloff BJ
J Investig Dermatol Symp Proc; 2000 Dec; 5(1):67-73. PubMed ID: 11147678
[TBL] [Abstract][Full Text] [Related]
2. Dermal injection of immunocytes induces psoriasis.
Wrone-Smith T; Nickoloff BJ
J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
[TBL] [Abstract][Full Text] [Related]
3. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
Nickoloff BJ
Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries.
Hern S; Allen MH; Sousa AR; Harland CC; Barker JN; Levick JR; Mortimer PS
Br J Dermatol; 2001 Jul; 145(1):45-53. PubMed ID: 11453906
[TBL] [Abstract][Full Text] [Related]
5. Xenotransplantation Model of Psoriasis.
Di Domizio J; Conrad C; Gilliet M
Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model.
Nickoloff BJ; Kunkel SL; Burdick M; Strieter RM
Am J Pathol; 1995 Mar; 146(3):580-8. PubMed ID: 7887440
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors.
Gilhar A; Ullmann Y; Kerner H; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2002 Aug; 119(2):384-91. PubMed ID: 12190861
[TBL] [Abstract][Full Text] [Related]
8. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
[TBL] [Abstract][Full Text] [Related]
10. Role of Angiogenic Growth Factors in Psoriasis: A Review.
Akhtar T; Wani WY; Kamal MA; Kaur R
Curr Drug Metab; 2018; 19(11):910-916. PubMed ID: 29663878
[TBL] [Abstract][Full Text] [Related]
11. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.
Nickoloff BJ; Wrone-Smith T
Am J Pathol; 1999 Jul; 155(1):145-58. PubMed ID: 10393847
[TBL] [Abstract][Full Text] [Related]
12. Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.
Canavese M; Altruda F; Silengo L; Castiglioni V; Scanziani E; Radaelli E
Histol Histopathol; 2011 Mar; 26(3):285-96. PubMed ID: 21210341
[TBL] [Abstract][Full Text] [Related]
13. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis.
Nickoloff BJ; Mitra RS; Varani J; Dixit VM; Polverini PJ
Am J Pathol; 1994 Apr; 144(4):820-8. PubMed ID: 7512793
[TBL] [Abstract][Full Text] [Related]
14. Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.
Guerrero-Aspizua S; García M; Murillas R; Retamosa L; Illera N; Duarte B; Holguín A; Puig S; Hernández MI; Meana A; Jorcano JL; Larcher F; Carretero M; Del Río M
Am J Pathol; 2010 Dec; 177(6):3112-24. PubMed ID: 20971736
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of psoriasis.
Gudjonsson JE; Johnston A; Dyson M; Valdimarsson H; Elder JT
J Invest Dermatol; 2007 Jun; 127(6):1292-308. PubMed ID: 17429444
[TBL] [Abstract][Full Text] [Related]
16. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model.
Raychaudhuri SP; Sanyal M; Weltman H; Kundu-Raychaudhuri S
J Invest Dermatol; 2004 Mar; 122(3):812-9. PubMed ID: 15086569
[TBL] [Abstract][Full Text] [Related]
17. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
[TBL] [Abstract][Full Text] [Related]
18. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
19. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice.
Gilhar A; David M; Ullmann Y; Berkutski T; Kalish RS
J Invest Dermatol; 1997 Sep; 109(3):283-8. PubMed ID: 9284091
[TBL] [Abstract][Full Text] [Related]
20. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis.
Henno A; Blacher S; Lambert CA; Deroanne C; Noël A; Lapière C; de la Brassinne M; Nusgens BV; Colige A
J Dermatol Sci; 2010 Mar; 57(3):162-9. PubMed ID: 20071151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
